89 FR 88 pgs. 37260-37261 - Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Type: NOTICEVolume: 89Number: 88Pages: 37260 - 37261
Pages: 37260, 37261Docket number: [Docket No. DEA-1357]
FR document: [FR Doc. 2024-09805 Filed 5-3-24; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1357]
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Pharmaron Manufacturing Services (US) LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 5, 2024. Such persons may also file a written request for a hearing on the application on or before July 5, 2024.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on March 25, 2024, Pharmaron Manufacturing Services (US) LLC, 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Oxymorphone | 9652 | II |
Noroxymorphone | 9668 | II |
The company plans to bulk manufacture the listed controlled substances for the purpose of producing material for clinical trials. No other activities for these drug codes are authorized for this registration.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-09805 Filed 5-3-24; 8:45 am]
BILLING CODE P